𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interferon antibodies in patients with chronic hepatitic C virus infection treated with recombinant interferon alpha-2α

✍ Scribed by Paula Bonetti; Giulio Diodati; Claudio Drago; Carla Casarin; Sergio Scaccabarozzi; Giuseppe Realdi; Arturo Ruol; Alfredo Alberti

Book ID
118567153
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
413 KB
Volume
20
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon antibodies may negate the ant
Interferon antibodies may negate the antiviral effects of recombinant α-interferon treatment in patients with chronic hepatitis B virus infection
✍ Dr. Anna Suk-Fong Lok; Ching-Lung Lai; Elsie Kit-Yee Leung 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

In a randomized controlled trial of recombinant a-2a interferon for chronic hepatitis B, interferon antibodies developed in 21 (39%) of 54 Chinese adults who received IFN. No correlation was observed between sex, age, pretreatment serum ALT level or liver histological findings and the development of

Interferon-alpha antibodies in patients
Interferon-alpha antibodies in patients with renal cell carcinoma treated with recombinant interferon-alpha-2A in an adjuvant multicenter trial
✍ Otto Prümmer; Delta-P Study Group 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 657 KB

Background. Prolonged therapy with interferon (IFN) may lead to the formation of IFN antibodies. Methods. Patients with renal cell carcinoma (n = 270) with advanced localized disease were randomized after complete tumor resection to receive treatment with adjuvant recombinant IFN-alpha-2a (rIFN-a2a